Dr. Howington received his Doctor of Pharmacy from the University of Kentucky College of Pharmacy in 2014. He attained board certification in critical care and pharmacotherapy in 2018 and transitioned into his faculty role in 2019. Additionally, Dr. Howington practices as an Emergency Medicine Clinical Pharmacy Specialist at UK HealthCare. Prior to beginning his clinical specialist role, he was an operations manager at UK HealthCare and a Clinical Staff Pharmacist. His current research interests include rabies post-exposure prophylaxis, sub-dissociative ketamine as an alternative to opioids for analgesia, and management of neonatal sepsis specifically focusing on the safety of ceftriaxone in neonates. Dr. Howington is also a member of the Emergency Medicine PHARMacotherapy research NETwork (EMPHARM-NET) which has afforded him the opportunity to work with emergency medicine pharmacy specialists across the nation.
PUBLICATIONS
Vaccines
COVID19
Infectious Disease
Pharmacy Practice
Emergency Medicine (rapid sequence intubation, diabetic ketoacidosis, sexually transmitted infections, etc.)
Rabies Post-exposure Prophylaxis
Acute Ischemic Stroke
Thrombolytics
The University of Kentucky College of Pharmacy (UKCOP) continues its legacy of leadership in Kentucky's pharmacy community as two faculty members have been elected to consecutive terms as president of the Kentucky Society of Health-System Pharmacists (KSHP).
